Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity was posted on October 12, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ASPR/BARDA Procurement and Late-stage Development of Smallpox Antiviral Drugs

Closed
SS-BARDA-2018Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts

Full Description

Show more
The purpose of this Other Than Small Business Sources Sought Notice is to use responses for planning potential future acquisitions. BARDA seeks pertinent marketplace data on availabilities and capabilities for late-stage development of a smallpox antiviral MCM candidate for stockpiling in the Strategic National Stockpile (SNS). BARDA intends to fund the procurement and development of both a nonparenteral and parental formulation of a smallpox antiviral candidate to address preparedness requirements and the needs of special populations. At a minimum, the drug should have established efficacy parameters as determined by the FDA in at least two appropriate orthopoxvirus animal model (e.g. Monkeypox, Rabbitpox). Information is being sought on availabilities, capabilities, and other pertinent marketplace data to strengthen BARDA's understanding of the current and future marketplace enhance its ability to obtain quality services economically, and to efficiently and lawfully establish potential vendor source files and listings. No contracts will be awarded under this notice. Please see the attached Sources Sought Notice.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS